A 2020 review on the safety of BPC-157 in preclinical (animal) studies states that the peptide did not show any test-related effects in the single-dose toxicity study and that it was well tolerated in repeat-dose evaluations.16 Other animal studies and reviews mention that BPC-157 has no reported toxicity or that it was without a lethal dose in toxicology studies.14 17 Even the authors of a small human study on BPC-157 for interstitial cystitis note that no one dropped out of the study, and no adverse events were reported.18 We want to highlight that most of the relevant studies have been conducted on animals, and more human research is needed
This includes what you eat, your B12 levels, and your health goals
Concerns may be higher with drugs that affect metabolism, blood sugar, sleep, or methyl-group pathways
If you shook the vial once briefly, the peptide is likely fine
The frequency of treatment can vary, ranging from weekly to monthly, depending on individual health needs and medical recommendations